ScienceDex / Researcher record
Douglas W.p. Hay
- Allinaire Therapeutics, Llc (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2026
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $1.5M in linked award amounts across 1 award record · Award-linked rank #13763.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11575793Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Douglas W.p. Hay as a PI. Multi-PI records show the full award amount for context.
- 1R44HL186831-01R44Contact PIAn anti-EMAP II monoclonal antibody as a first-in-class treatment for Group III pulmonary hypertension patients with chronic obstructive pulmonary disease$1.5Maward amount
Award organization
Organizations that administered FY2026 awards listing Douglas W.p. Hay as a PI.
FY2026 award administered by Allinaire Therapeutics, Llc (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardAllinaire Therapeutics, Llc
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding